The deal is expected to be finalized by the first half of this year.

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), explains why this resource is an asset, specifically for research in the psychedelic space.

The latest news for pharma industry insiders.

The move—one that meet’s industry standards—confirms the Cryoport company’s commitment to providing quality and safety in the cold chain solutions space.

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jon Kostas, executive director, Association for Prescription Psychedelics (APP), provides a peek into what the association has set out to accomplish.

The latest news for pharma industry insiders.

In the final part of this roundtable discussion, a panel of subject matter experts discuss what the future holds for this technology, why end-to-end visibility is necessary in healthcare, and the opportunities for greater RFID adoption that lie ahead.

A forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.

The latest news for pharma industry insiders.

Lisa Arthurs, VP, trade, Two Labs, discusses a roundtable discussing women in trade as well as empowering future leaders.

Is this level of involvement with HRSNs associated with higher burnout?

This bucket of Pharma Commerce coverage is highly powered by digital solutions.

Pharma Commerce was on the road extensively throughout 2024, and plenty of insight was gathered along the way.

A dive into the top articles in this sector making waves this year.

Check out our top five most engaged social media posts from the year 2024.

The top five episodes of our podcast in the year 2024, highlighted.

The latest in container tech and temperature-monitoring truly powered the content.

The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.

The latest news for pharma industry insiders.

Jon Hamrick, partner, Curatio Scientia Advisors, discusses upcoming industry challenges at this year's Trade & Channel Strategies Conference in Philadelphia.

How will supply chains in the space continue to develop?

The latest news for pharma industry insiders.

Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses the difference between return on invested capital in pharma compared to other organizations.

In the fifth part of this roundtable discussion, subject matter experts discuss the role that various GS1 initiatives have played, and provide a breakdown of stakeholders who have benefitted greatly from RFID.